首页 >
法规速递
-
Page: Union list of critical medicines-2026/1/19
2026-01-20查看详情 > -
Document: Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2026-2026/2/19
2026-02-27查看详情 > -
Document: QRD Appendix II - Medical Dictionary for Regulatory Activities terminology to be used in section 4.8 'undesirable effects' of the summary of product characteristics (Cover page)-2026/3/25
2026-03-26查看详情 > -
Document: Agenda of the COMP Meeting 14-16 April 2026-2026/5/4
2026-05-06查看详情 > -
Document: IRIS guide for applicants - How to create, submit and manage IRIS applications, for industry and individual applicants-2026/6/15
2026-06-16查看详情 > -
Topical Dermatologic Corticosteroids: In Vivo Bioequivalence (Draft)-2022/10/21
2022-11-15查看详情 > -
国家药监局关于修订正清风痛宁口服制剂和新生化制剂说明书的公告（2023年第40号）-2023/4/13
2023-04-14查看详情 > -
《药品经营和使用质量监督管理办法》解读（三）-2023/10/13
2023-10-16查看详情 > -
国家药监局药审中心关于发布《治疗子宫内膜癌新药临床研发技术指导原则（试行）》的通告（2025年第2号）-2025/1/9
2025-01-10查看详情 > -
Page: Substance and product data management services-2025/2/14
2025-02-18查看详情 >
